BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29228232)

  • 1. External validation of two web-based postoperative nomograms predicting the probability of early biochemical recurrence after radical prostatectomy: a retrospective cohort study.
    Yoneda K; Utsumi T; Somoto T; Wakai K; Oka R; Endo T; Yano M; Kamiya N; Hiruta N; Suzuki H
    Jpn J Clin Oncol; 2018 Feb; 48(2):195-199. PubMed ID: 29228232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
    Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI
    J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.
    Sandeman K; Eineluoto JT; Pohjonen J; Erickson A; Kilpeläinen TP; Järvinen P; Santti H; Petas A; Matikainen M; Marjasuo S; Kenttämies A; Mirtti T; Rannikko A
    PLoS One; 2020; 15(7):e0235779. PubMed ID: 32645056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of pre- and postoperative nomograms used to predict the pathological stage and prostate cancer recurrence after radical prostatectomy: a multi-institutional study.
    Hinev AI; Anakievski D; Kolev N; Marianovski V; Hadjiev V
    J BUON; 2011; 16(2):316-22. PubMed ID: 21766504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
    Suardi N; Porter CR; Reuther AM; Walz J; Kodama K; Gibbons RP; Correa R; Montorsi F; Graefen M; Huland H; Klein EA; Karakiewicz PI
    Cancer; 2008 Mar; 112(6):1254-63. PubMed ID: 18286530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
    Yee DS; Shariat SF; Lowrance WT; Maschino AC; Savage CJ; Cronin AM; Scardino PT; Eastham JA
    BJU Int; 2011 Aug; 108(4):502-7. PubMed ID: 21050364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancer.
    Kang M; Jeong CW; Choi WS; Park YH; Cho SY; Lee S; Lee SB; Ku JH; Hong SK; Byun SS; Jeong H; Kwak C; Kim HH; Lee E; Lee SE;
    PLoS One; 2014; 9(6):e100053. PubMed ID: 24936784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group.
    Teeter AE; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
    Urology; 2013 Jul; 82(1):53-8. PubMed ID: 23806388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy.
    Fajkovic H; Mathieu R; Lucca I; Hiess M; Hübner N; Al Hussein Al Awamlh B; Lee R; Briganti A; Karakiewicz P; Lotan Y; Roupret M; Rink M; Kluth L; Loidl W; Seitz C; Klatte T; Kramer G; Susani M; Shariat SF
    Urol Oncol; 2016 May; 34(5):233.e1-6. PubMed ID: 26973136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram.
    Pompe RS; Bandini M; Preisser F; Marchioni M; Zaffuto E; Tian Z; Salomon G; Schlomm T; Huland H; Graefen M; Tilki D; Shariat SF; Karakiewicz PI
    Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):386-393. PubMed ID: 29487397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pathological stage at radical prostatectomy: do commonly used prostate cancer nomograms apply to men from Far North Queensland?
    Nesbitt AL; Kapoor J; Piesse C; Evans G; Antoniou S; Smith P; Pridgeon SW
    ANZ J Surg; 2019 Jan; 89(1-2):111-114. PubMed ID: 30560567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nomogram provides improved accuracy for predicting biochemical recurrence after radical prostatectomy.
    Xia HZ; Bi H; Yan Y; Yang B; Ma RZ; He W; Zhu XH; Zhang ZY; Zhang YT; Ma LL; Hou XF; Wirth GJ; Lu J
    Chin Med J (Engl); 2021 Jun; 134(13):1576-1583. PubMed ID: 34133352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy.
    Schroeck FR; Kattan MW; Moul JW; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Sun L; Freedland SJ
    BJU Int; 2010 Jun; 105(12):1654-9. PubMed ID: 19912203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer.
    Roumiguié M; Beauval JB; Filleron T; Benoit T; Rischmann P; de la Taille A; Salomon L; Soulié M; Malavaud B; Ploussard G
    BJU Int; 2014 Dec; 114(6b):E113-E119. PubMed ID: 24684584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation and comparison of two nomograms predicting the probability of Gleason sum upgrading between biopsy and radical prostatectomy pathology in two patient populations: a retrospective cohort study.
    Utsumi T; Oka R; Endo T; Yano M; Kamijima S; Kamiya N; Fujimura M; Sekita N; Mikami K; Hiruta N; Suzuki H
    Jpn J Clin Oncol; 2015 Nov; 45(11):1091-5. PubMed ID: 26292699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy.
    Blas L; Shiota M; Takamatsu D; Kinoshita F; Matsumoto T; Lee K; Monji K; Kashiwagi E; Inokuchi J; Eto M
    World J Urol; 2023 Jan; 41(1):43-50. PubMed ID: 36527468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A post-radical-prostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis.
    O'Brien BA; Cohen RJ; Wheeler TM; Moorin RE
    BJU Int; 2011 Feb; 107(3):389-95. PubMed ID: 20707795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy.
    Schroeck FR; Sun L; Freedland SJ; Jayachandran J; Robertson CN; Moul JW
    Prostate Cancer Prostatic Dis; 2008; 11(4):371-6. PubMed ID: 18427570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
    Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
    BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.